PPT-Canadian Cardiovascular Society Antiplatelet Guidelines

ASA NSAID DrugDrug Interaction Working Group Alan D Bell MD CCFP Wee Shian Chan MD FRCP Objectives Interpret the Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet therapy in patients . Cairns MD L Brent Mitchell MD Laurent Macle MD Ian G Stiell MD David Gladstone MD Michael Sean McMurtry MD Stuart Connolly MD Jafna L Cox MD Paul Dorian MD Noah Ivers MD Kori Leblanc PharmD Stanley Nattel MD and Jeff S Healey MD for the CCS Atrial Antiplatelet Guidelines. PERIOPERATIVE MANAGEMENT OF ANTIPLATELET THERAPY. Working Group: . James D. Douketis MD, FRCP(C); A. Graham . Turpie. MD, FRCP(C). Objectives. Interpret the Canadian Cardiovascular Society . Antiplatelet Guidelines. Antiplatelet. Therapy for . Vascular Prevention in Patients with Peripheral Arterial Disease. Working. Group. : A. Roussin, MD, FRCP; Thomas F. Lindsay, MD, CM. , FRCSC. Objectives. Antiplatelet Guidelines. MANAGEMENT OF ANTIPLATELET THERAPY IN ASSOCIATION WITH MINOR BLEEDING. Working Group: . James D. Douketis MD, FRCP(C); A. Graham . Turpie. MD, FRCP(C). Objectives. Interpret the Canadian Cardiovascular Society . Antiplatelet Guidelines. USE OF ANTIPLATELET THERAPY IN WOMEN WHO ARE PREGNANT OR BREASTFEEDING. Working Group: . Wee . Shian. Chan MD, FRCP(C); James D. Douketis MD, FRCP(C). Antiplatelet. Guidelines. INTERACTION BETWEEN CLOPIDROGEL AND PROTON PUMP INHIBITORS. Working Group. : Wee Shian Chan, MD, FRCP; Alan D. Bell, MD, CCFP. Objectives. Interpret the . Canadian Cardiovascular Society . Antiplatelet Guidelines. HEART FAILURE. Working Group: . Alan D. Bell, MD, CCFP; James D. . Douketis. , MD, FRCP. Objectives. Interpret . the . Canadian Cardiovascular Society Guideline . recommendations . Antiplatelet Guidelines. MANAGEMENT OF ANTIPLATELET THERAPY IN ASSOCIATION WITH MINOR BLEEDING. Working Group: . James D. Douketis MD, FRCP(C); A. Graham . Turpie. MD, FRCP(C). Objectives. Interpret the Canadian Cardiovascular Society . Antiplatelet Guidelines. . ANTIPLATELET THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE. Working. Group: . Neesh. . Pannu. , MD, SM, FRCP; Alan D. Bell, MD, CCFP. Interpret the Canadian Cardiovascular Society Guideline recommendations regarding the use antiplatelet . ASA – NSAID Drug/Drug Interaction. Working Group: . Alan D. Bell, MD, CCFP; Wee . Shian. Chan, MD, FRCP. Objectives. Interpret. . the . Canadian Cardiovascular Society Guideline recommendations regarding the use of antiplatelet therapy in patients . October 2018. Endorsed by the Canadian Association . of Emergency Physicians (CAEP). 2018 STEMI Guideline Authors. Graham C. Wong MD MPH (Co-Chair), Michelle Welsford MD, Craig Ainsworth MD, Wael Abuzeid MD MSc, Christopher Fordyce MDCM MHS MSc, Jennifer Greene BSc ACP, Thao Huynh MD MSc PhD, Laurie Lambert PhD, Michel Le May MD, Sohrab Lutchmedial MDCM, Shamir Mehta MD MSc, Madhu Natarajan MD MSc, Colleen Norris RN, MN, PhD, Christopher Overgaard MD MSc, Michele Perry . www.onlinecjc.com. ).  . If your reuse request qualifies as medical institution internal education, you may reuse the material under the following conditions:. You . must cite the Canadian Journal of Cardiology and the Canadian . Magda . Mitu. , Ph.D.. PROVAS IV, Timișoara, 2016. Asimptomatic. HTA diagnosticată de 1 an, caracterizată prin valori intermitent crescute (TA max . ꞊ 160/100 mmHg. ), tratat în ambulator cu indapamid și BCC. Executive committee: . Dr. Mary-Ann . Fitzcharles. , Peter A. . Ste. -Marie, . Dr. Don L. Goldenberg, Dr. John X. Pereira, Dr. Susan Abbey, . Dr. . Manon. . Choini. ère, Dr. Gordon Ko, Dr. Dwight Moulin, .